SANDERS CHARLES A

Insider Buys Quantity –
3
2012-03-13PurchaseBioCryst Pharmaceuticals, Inc.
BCRX
director
2,000
0.0042%
$5.20$10,400-29.47%
2010-02-08PurchaseBioCryst Pharmaceuticals, Inc.
BCRX
director
5,000
0.0116%
$6.66$33,300-15.27%
2009-05-18SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,333
0.0019%
$28.44$94,791+30.05%
2009-05-11SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,333
0.0019%
$30.41$101,357+22.95%
2009-05-04SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,334
0.0019%
$30.08$100,287+23.4%
2008-05-27SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,333
0.0024%
$26.74$89,128+6.72%
2008-05-20SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,333
0.0024%
$27.60$92,001+5.48%
2008-05-13SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,334
0.0024%
$27.19$90,658+7.43%
2007-05-07SaleVertex Pharmaceuticals Incorporated
VRTX
director
10,000
0.0078%
$30.53$305,300-13.25%
2006-12-08SaleVertex Pharmaceuticals Incorporated
VRTX
director
2,000
0.0018%
$42.95$85,900-27.03%
2006-12-07SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,000
0.0027%
$43.97$131,910-27.62%
2006-12-06SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,000
0.0027%
$44.71$134,130-29.07%
2006-12-05SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,000
0.0026%
$44.51$133,530-29.14%
2006-12-04SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,000
0.0027%
$44.28$132,840-28.47%
2006-12-01SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,000
0.0026%
$43.86$131,580-28.34%
2006-11-30SaleVertex Pharmaceuticals Incorporated
VRTX
director
3,000
0.0027%
$44.54$133,620-28.58%
2003-11-12PurchaseVertex Pharmaceuticals Incorporated
VRTX
director
20,000
0.0256%
$8.28$165,600+17.85%